Osstem Implant's market capitalization ranking, which was suspended from trading after a massive embezzlement incident, has risen vertically from the recent crash.
According to the Korea Exchange on the 29th, on the KOSDAQ market on December 30, the last trading day of last year, Osstem Implant closed at 142,700 won, up 0.42% from the previous trading day.
The stock price climbed 27.41% in the month of December.
However, ahead of the opening on the 3rd, the first trading day of the new year, the Osstem Implant transaction was suspended due to a notice of embezzlement.
As a result, the stock price of Osstem Implant stopped at 142,700 won just before the suspension of trading throughout January.
The market cap remained unchanged as trading was suspended.
As of the day before the transaction suspension, Osstem Implant's market cap stood at KRW 2.38 trillion, ranking 22nd on the KOSDAQ.
However, on January 28, a month later, Osstem Implant's KOSDAQ market capitalization jumped to 15th.
On the 27th, when the KOSDAQ fell 3.73%, it climbed to 14th place.
The market cap of Osstem Implant remains the same, but the market caps of other top-ranked KOSDAQ stocks have decreased due to a sharp drop in stock prices.
During the month of January, the KOSDAQ fell 15.58%.
Looking at the January fluctuation rates of other KOSDAQ stocks with similar market caps, EcoPro -44.51%, Alteogen -36.59%, Chunbo -26.33%, Afreeca TV -24.52%, ST Pharm -24.21%, Com2uS -23.83%, etc. more than 20% There are many cases where it fell, but Osstem Implant unintentionally maintained a flat position due to the suspension of trading, so it saved the market from the crash.
Mr. Lee, who is accused of embezzling 221.5 billion won of company money while working as an Osstem Implant financial management employee, has been arrested and sent to the prosecution.
The Korea Exchange will determine whether Osstem Implant is eligible for listing eligibility substantive screening by February 17th, and inform the continuation or cancellation of trading suspension.
After that, if it becomes the subject of substantive screening for listing eligibility, it goes to the Corporate Review Committee to decide whether to maintain or cancel the listing.